barclays disruptive technologies conference bayer crop science handout 2024.06.11 · page 14 of 20
The slide uses a split-screen approach to contrast market-wide growth with company-specific growth targets.
Consulting deck · market_sizing · size_opportunity · overcrowded density
Slide locked Sign in to view
Slide schematic 7/9
callout 0/1 chart 1/1 list 1/1 metric 1/2 paragraph 1/1 source-note 1/1 title 2/2
2 without position callout 1 · metric 1
calloutmetric · primary
Components 9
callout bar-stacked bullet big-number primary paragraph source-note action-title headline
Tools 6
Contrast Pairs loop · 70%
Two-panel split: Global Biologicals Market (left) vs Bayer Biologicals Opportunity (right).
Goal Gradient Effect loop · 60%Frames a 13-year growth path with explicit progress markers (CAGR arrows).
Action Titles slide · 90%Title 'Biologicals Market Expected to More than Double to €30bn by 2035' is an insight headline.
Concrete Language slide · 88%Specific: €12bn 2022 → €30bn 2035, 7% market CAGR, Bayer 17% CAGR €200m → >€1.5bn.
Thesis archetype slide · 50%We aim to Outgrow the Market with a 17% CAGR
Visual Hierarchy slide · 75%Stacked bars on left and bold €200m / €1.5bn / 17% on right dominate.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.